Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Diffusion Pharmaceuticals Inc (NQ: DFFN ) 4.400 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 16, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Diffusion Pharmaceuticals Inc Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) Leading the Way in Wednesday Trading Based on Percentage Gain August 16, 2023 Via Investor Brand Network Exposures COVID-19 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ranger Oil Corporation (Nasdaq – ROCC), Univar Solutions Inc. (NYSE - UNVR), Life Storage, Inc. (NYSE - LSI), Diffusion Pharmaceuticals Inc. (Nasdaq- DFFN) April 14, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Univar Solutions Inc. (NYSE - UNVR), Life Storage, Inc. (NYSE - LSI), World Wrestling Entertainment, Inc. (NYSE - WWE), Diffusion Pharmaceuticals Inc. (Nasdaq - DFFN) April 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heska Corporation (Nasdaq – HSKA), Life Storage, Inc. (NYSE - LSI), World Wrestling Entertainment, Inc. (NYSE - WWE), Diffusion Pharmaceuticals Inc. (Nasdaq - DFFN) April 03, 2023 From Brodsky & Smith LLC Via GlobeNewswire DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN March 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire DFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to Shareholders March 30, 2023 From Halper Sadeh LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diffusion Pharmaceuticals Inc. (Nasdaq- DFFN), U.S. Xpress Enterprises, Inc. (NYSE – USX), TCR² Therapeutics Inc. (Nasdaq – TCRR), Costar Technologies, Inc. (OTC – March 30, 2023 From Brodsky & Smith LLC Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.